4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-23-007222
CHIEF EXECUTIVE OFFICER gave up 44,025 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2023-11-17 | Shares withheld for taxes | −44,025 | $1.50 | $66,038 | 5,977,848 | D |
Loading xslF345X05/ownership.xml…